Sam Clark, Terran Biosciences CEO
Sanofi offloads two late-stage drugs to virtually unknown neuro and psychedelic biotech
A fledgling New York biotech has managed to catch the eye of Sanofi, signing a new collaboration with the pharma giant to acquire two of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
